1[1]Delgado G, Bundy B, Zaino R, et al. Prospective surgicalpathological study of disease- free interval in patients with stage Ⅰ B squamous cell carcinoma of thr cervix: A Gynecologic Oncology Group study. Gynecol Oncol 1990, 38:352
2[2]Sevin BU, Lu Y, Bloch BA, et al. Surgical defined prognostic parameters in patients with early cervical carcinoma: A multivariate survival tree analysis. Cancer, 1996, 78:1438
3[3]Kinney WK, Alvarez RD, Reid GC, et al. Value of adjuvant whole- pelvis irradiation after Wertheim hysterectomy for earlystage squamous carcinoma of the cervix with pelvic nodal metastasis: A matched-control study. Gynecol Oncol, 1989, 34:258
4[4]Stehman FB, Bundy BN, Thomas G, et al. Hydroxyurea versus mosonidazole with radiation in cervical carcinoma: Longterm follow - up of a Gynecologic Oncology Group trial. J Gin Oncol, 1993, 11:1523
5[5]Thomas G, Dembo a, Fyles A, et al. A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5 - fluorouracil in locally advanced cervical cancer. GynecolOncol, 1998, 69:137
6[6]Thomas G, Dembo A, Beale F, et al. Concurrent radiation, mitomycin C and 5- fluorouracilnin poor prognosis carcinoma of cervix: Preliminary results of a phase Ⅰ～Ⅱ study. Int J Radiat Oncol Biol Phys, 1984, 10:1785
7[7]Thomas G, Dembo A, Fyles A, et al. Concurrent chemoradiation in advanced cervical cancer. Gynecol Oncol, 1990, 38:446
8[8]AlbertsDs, KronalR, Baker LH, et al. Phaes Ⅱ randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix. A Southwest Oncology Group study. J Clin Oncol, 1987, 5:1791
9[9]Omura GA, Blessing J, Vaccarello L, et al. A randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfmide in advanced squamous carcinoma of the cervix: A Gynecologic Oncology Group study. J Glin Oncol, 1997, 15:165
10[10]Vokes EE, Weichselbaum RR. Concomitant chemotherapy: rational and clinical experience in patients with solid tumors. J Clin Oncol, 1999, 8:911
